Scientists Unveil Advanced Microscopy to Observe Flu Virus Entry

A groundbreaking study from researchers in Switzerland and Japan has developed a new microscopy technique that allows scientists to observe the influenza virus as it enters human cells. This innovative method, called virus-view dual confocal and atomic force microscopy (ViViD-AFM), combines two powerful imaging technologies to provide unprecedented real-time insights into the virus’s invasion process.

The influenza virus, notorious for its seasonal resurgence, infiltrates the human body through tiny droplets we inhale. Once inside, it uses two key proteins, hemagglutinin (HA) and neuraminidase (NA), to latch onto cells, initiating a complex process of infection. Traditional microscopy techniques have struggled to capture the rapid and minuscule movements involved in this process, leaving many aspects of the virus’s behavior poorly understood.

With the advent of ViViD-AFM, researchers can now examine living human cells in extraordinary detail. For the first time, they have visualized the intricate dance between the influenza virus and its target cells. The study revealed surprising behavior from the cells themselves, which actively engaged with the virus rather than passively allowing entry.

Yohei Yamauchi, a researcher at ETH Zurich, remarked, “The infection of our body cells is like a dance between virus and cell.” The researchers observed how individual influenza virus particles navigated the cell surface under various conditions, including scenarios where specific viral proteins were inhibited or when different strains of the virus were introduced.

The study highlighted the importance of the cell’s membrane, which changes shape during the virus’s entry. By utilizing fluorescent tags that make the virus visible, the new technique enabled scientists to track the virus without needing additional labels. This capability allows for simultaneous visualization of the viral proteins and the cellular structure, providing a comprehensive understanding of their interactions.

The findings indicated that influenza viruses require larger surface bulges on the cell, created by the protein actin, to facilitate entry. These bulges were not hindered by certain inhibitors, suggesting that the mechanism may overlap with other cellular processes. Once the virus binds to receptor clusters, it triggers signals that prompt the cell to envelop the virus in a clathrin coat, ultimately pulling the virus inward and encapsulating it in a vesicle for transport to the cell nucleus.

The implications of this advanced microscopy technique extend beyond just studying influenza. Researchers anticipate that ViViD-AFM could become a vital tool in evaluating the efficacy of antiviral medications in real time, as well as examining the behavior of various viruses and the interactions of vaccines with human cells.

This breakthrough offers a new “window” into cellular activity, potentially reshaping our understanding of how viruses operate and how medicines can be developed to combat them. The research findings have been published in the journal PNAS, marking a significant step forward in virology and drug research.